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SUMMARY – The aim of the study was to assess the incidence and etiology of repeated bladder 
outlet obstruction (BOO) after kidney transplantation and to analyze the results of transurethral in-
cision of the prostate/transurethral resection of the prostate (TUIP/TURP) in the early period after 
kidney transplantation. The study included 24 male patients having undergone renal transplantation 
and early transurethral surgery for BOO in our institution between 2005 and 2011. TUIP or TURP 
was performed depending on the etiology of BOO. The indications for transurethral surgery were 
repeated urinary retention despite therapeutic attempts with alpha-receptor antagonists, or repeated 
residual urine with renal transplant dysfunction and/or consequent urinary tract infection. Preope-
rative assessment included past medical history, clinical examination, PSA, volume of residual urine 
estimated with ultrasound, and urinary culture. Among 345 male patients having undergone renal 
transplantation, repeated BOO was noted in 24 patients. TUIP was performed in 19 and TURP in 
five patients. The mean age of our patients was 52 (range, 33-73) years and the mean time on dialysis 
7.43 years (range, 4 months to 25 years). The procedure was performed on the mean of day 16 (ran-
ge, 14-29) after transplantation and urethral catheter was removed on the mean of day 3.3 (range, 
2-9) after the procedure. The etiology of BOO was bladder neck contracture in nine and benign 
prostatic hyperplasia in 15 patients. In all patients, surgical procedures were performed without any 
complication. Restoration of urinary bladder function was complete in all patients. In conclusion, 
early transurethral treatment of repeated BOO is a safe procedure with excellent results following 
renal transplantation. 
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Introduction
The incidence of benign prostatic hyperplasia 
(BPH) increases with age, and more than 50% of men 
have histologic evidence of BPH by age 601. Over the 
last decade, an increased proportion of renal trans-
plant recipients older than 60 have been recorded, with 
the majority of them receiving transplant through 
the Eurotransplant Senior Program, which allocates 
kidneys from elderly donors to equally old recipients. 
Thus, the number of transplanted male patients with 
postoperative voiding dysfunction is increasing. If left 
untreated, BPH poses the risk of numerous complica-
tions including acute urinary retention, recurrent uri-
nary tract infections, and allograft failure.
The risk factors that have an important role in re-
peated urinary retention after kidney transplantation 
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include occult BPH, bladder neck contracture, urethral 
strictures, dysfunctional bladder, urinary infections, 
diabetes, and neurologic disorders. In some patients, 
urinary obstruction can be detected by pretransplant 
screening, but many patients do not develop symp-
toms until urine flow is restored after transplantation. 
In most of these patients, selective alpha-adrenergic 
receptor antagonists are effective in preventing next 
episodes of urinary retention. However, in some renal 
transplant recipients, urinary retention is repeated de-
spite the use of alpha-adrenergic blockers. 
The aim of this study was to assess the incidence 
of repeated bladder outlet obstruction (BOO) after 
kidney transplantation, and to analyze the results of 
transurethral incision of the prostate (TUIP)/tran-
surethral resection of the prostate (TURP) in the 
early posttransplant period. 
Patients and Methods
From January 2005 to January 2011, renal trans-
plantation was performed in 345 male patients with 
end stage renal disease at Zagreb University Hospital 
Center. Our study included 24 patients having under-
gone renal transplantation and transurethral surgical 
procedure for repeated BOO in the early posttrans-
plant period. Preoperative assessment included past 
medical history, clinical examination, PSA, prostate 
volume and residual urine volume estimation with ul-
trasound (US). Renal transplant technique was per-
formed with extraperitoneal approach and end to side 
anastomosis of the donor to the recipient iliac vessels. 
Ureteral implantation to the bladder was performed 
in an extravesical antireflux technique with double-J 
catheter for 6-8 weeks. In patients with pretransplant 
diuresis, urethral catheter was removed on postop-
erative day 8. In cases of urinary retention or residual 
urine with transplant dysfunction and/or urinary tract 
infection, urethral re-catheterization was done and 
therapy with selective alpha-adrenergic antagonists 
was started. The next attempt at catheter removal was 
made three days after the introduction of alpha-adren-
ergic blocker therapy. In patients that had been anuric 
before transplantation, alpha-adrenergic blockers were 
administered from posttransplant day 8, and urethral 
catheter was removed on posttransplant day 11. The 
indications for TUIP were repeated urinary reten-
tion despite therapeutic attempts with alpha-receptor 
blockers, or residual urine with renal transplant dys-
function and/or urinary tract infection. In all patients, 
independently of prostate volume, complete opening 
of the bladder neck was obtained. TURP was reserved 
for patients with prostatic median lobe. In all patients, 
initial immunosuppression consisted of cyclosporine 
(at doses of 150-200 µg/mL), mycophenolate mofetil 
(2x1 g) and steroids. Follow-up was restricted to the 
first 120 days of transplantation. Descriptive statisti-
cal analysis was performed. 
Results
Among 345 transplanted male patients, data were 
analyzed for 24 patients (mean age 52, range 33-73) 
with repeated urinary retention despite therapeutic 
attempts with alpha-adrenergic receptor antagonists. 
Another 72 transplanted patients with voiding dys-
function after urethral catheter removal, who re-
sponded well to therapy with alpha-adrenergic block-
ers, were not included in this study. The underlying 
nephrologic conditions in study patients were chronic 
glomerulonephritis in 13 (54%), cystic kidney dis-
ease in four (17%), hypertensive nephropathy in three 
(13%), diabetic nephropathy in two (8%) and inter-
stitial nephritis in two (8%) patients. The mean time 
on dialysis was 7.43 years (range from 4 months to 25 
years). Twenty-two (92%) patients received first trans-
plant and two (8%) patients second transplant. In one 
patient, kidney from a living donor was transplanted. 
Before renal transplantation, eight (33%) patients 
were anuric, 11 (46%) had diurnal urine volumes <500 
mL, four (17%) had 500-1500 mL, and only one (4%) 
patient had normal urine production of >1.5 L/day. 
There was only one patient with evidence of BPH be-
fore transplantation. 
After transplantation and urethral catheter remov-
al on postoperative day 8 (day 11 in anuric patients 
before transplantation), the indications for re-cath-
eterization were acute urinary retention in 17 (71%) 
and residual urine exceeding 300 mL in seven (29%) 
patients. Increased residual urine volume led to renal 
transplant dysfunction in two patients and to recur-
rent urinary tract infection in another three patients. 
All patients were treated with alpha-adrenergic block-
ers for at least 3 days, and the catheter was removed 
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again, unfortunately, with repeated urinary retention. 
Urethrocystoscopy revealed bladder neck contracture 
in nine and BPH in 15 patients, five of the latter with 
median prostatic lobe. TUIP was performed in 19 and 
TURP in five patients at a mean of 16.3 (12-29) days 
of transplantation. In all patients, surgical procedures 
were performed without any complication. Urethral 
catheter was removed at a mean of 3.3 (2-9) days af-
ter the procedure. The mean postoperative maximum 
flow rate was 17.4 mL/s (12-32) 10 days after the pro-
cedure and postvoiding residual urine was not signifi-
cant. Surgical procedure for BOO did not alter renal 
function. All patients had the ureteral stent in place. 
Restoration of urinary bladder function was complete 
in all patients. 
Discussion 
In recent years, the lower urinary tract, which col-
lects urine from transplanted kidney has attracted 
little clinical and scientific attention, but low-pressure 
urine storage and effective bladder emptying with no 
residual volume is a prerequisite for prolonged and 
sufficient renal allograft function. There is no reason 
to suspect that the actual incidence of BOO should be 
greater in the renal transplant population. Frequency 
and nocturia are two main characteristics of lower uri-
nary tract function after renal transplantation, prob-
ably through the combination of high fluid intake and 
long-term dysfunctional urinary bladder during renal 
replacement therapy. 
Our data revealed a high rate of voiding dysfunc-
tion in male transplant recipients, and one quarter of 
our transplanted patients with voiding dysfunction 
required surgical treatment in the early posttrans-
plant period. There are several reports of BOO from 
posttransplant BPH, and many of these patients re-
quired surgical procedures such as TUIP or TURP 
to alleviate urinary obstruction2-5. Urinary retention 
as evidenced by the high level of residual urine in our 
patients induced recurrent urinary tract infections and 
seriously affected graft function. In the renal trans-
plant population, urinary tract infections have been 
shown to be an independent risk factor for graft loss6. 
Bladder neck and prostate-related surgeries were not-
ed in 7% of our transplanted patients. This frequency 
is similar to that reported in the general population7. 
There are no published studies of medical therapy for 
BOO in renal transplant patients, but this would be 
the first-line therapy as in the general population. 
Regarding surgical therapy, literature reports are con-
flicting when discussing whether it is better to per-
form TUIP or TURP procedure before or after trans-
plantation. If performed before transplantation while 
the patient is still oliguric, urethral scarring may de-
velop8. If performed after transplantation, there is a 
study report on 25% incidence of major postoperative 
complications including death5. Our experiences with 
TUIP as a minimally invasive surgical procedure, and 
TURP which was reserved only for patients with pro-
static median lobe, were completely different. These 
procedures resulted in excellent restoration of urinary 
bladder function, without any complication in all our 
patients. Similar results with no complications have 
been reported by Koziolek et al9. Although we had only 
one patient with evidence for BPH before transplan-
tation, we strongly recommend evaluation for urologic 
abnormalities including BPH, bladder neck contrac-
ture or urethral stricture before transplant listing. This 
evaluation, of course, is only possible in patients with 
maintained urine production. Postvoid residual vol-
ume is an excellent objective screening test10. A small 
bladder, observed in eight of our patients, did not im-
pair graft function postoperatively, and did achieve a 
favorable bladder capacity 2 months after transplan-
tation. Another investigation of 102 patients showed 
the bladder capacity and compliance to have returned 
to normal in approximately 24 weeks of kidney trans-
plantation11. The administration of alpha-adrenergic 
receptor antagonists before catheter removal in pa-
tients at risk may be useful because a high percentage 
of these patients develop postoperative voiding dys-
function. In patients having suffered from anuria for 
a long time before transplantation, we administered 
alpha-adrenergic blockers from posttransplant day 8 
(3 days before urethral catheter removal) in order to 
reduce the risk of acute urinary retention and to en-
hance bladder neck relaxation. Further studies should 
evaluate whether it is better to prescribe these drugs 
routinely in older male recipients before removing 
urethral catheter. 
Our data showed that TUIP or TURP could be 
safely performed early after renal transplantation in 
patients with repeated BOO who did not respond 
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to treatment with selective alpha-adrenergic recep-
tor antagonists. These procedures should be reserved 
for transplanted patients with repeated acute urinary 
retention or residual urine volume, which leads to re-
nal transplant dysfunction or recurrent urinary tract 
infections. 
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Sažetak
TRANSURETRALNA INCIZIJA/RESEKCIJA PROSTATE (TUIP/TURP) U OPERACIJSKOM LIJEČENJU 
PONOVLJENE OPSTRUKCIJE VRATA MOKRAĆNOg MJEHURA U RANOM RAZDOBLJU NAKON 
PRESAĐIVANJA BUBREgA
I. Mokos, Ž. Kaštelan, N. Bašić-Jukić, P. Kes i J. Pasini
  Cilj rada bio je procijeniti incidenciju i etiologiju ponovljene opstrukcije vrata mokraćnog mjehura (BOO) nakon pre-
sađivanja bubrega i analizirati rezultate transuretralne incizije prostate (TUIP)/transuretralne resekcije prostate (TURP) u 
ranom razdoblju nakon presađivanja bubrega. Istraživanjem su obuhvaćena 24 bolesnika u kojih je učinjena transplantacija 
bubrega i transuretralni zahvati zbog BOO u ranom poslijetransplantacijskom razdoblju u našoj ustanovi između 2005. 
i  2011. godine. Ovisno o etiologiji BOO učinjen je TUIP ili TURP. Indikacije za transuretralni operacijski zahvat bile 
su: ponovljeno zadržavanje mokraće unatoč terapiji selektivnim antagonistima alfa adrenergičnih receptora ili ostatna 
mokraća s pogoršanjem funkcije bubrežnog presatka i/ili posljedičnom infekcijom mokraćnog sustava. Prijeoperacijska 
obrada uključivala je anamnezu, klinički pregled, PSA, određivanje volumena ostatne mokraće ultrazvukom i urinokul-
turu. Od 345 muška bolesnika podvrgnutih presađivanju bubrega u 24 bolesnika je zabilježena opetovana BOO. U 19 
bolesnika je učinjen TUIP, a u 5 bolesnika TURP. Prosječna dob bolesnika bila je 52 (raspon 33-73) godine. Prosječno 
vrijeme provedeno na dijalizi iznosilo je 7,43 (raspon od 4 mjeseca do 25 godina) godine. Zahvat je učinjen 16. dana (14-
29) nakon transplantacije. Urinarni kateter se vadio prosječno 3,3 (2-9) dana nakon zahvata. Uzrok BOO u 9 bolesnika je 
bila kontraktura vrata mokraćnog mjehura, te hiperplazija prostate u 15 bolesnika. Zahvati su učinjeni bez ikakvih kom-
plikacija u svih bolesnika. Ponovna uspostava funkcije mokraćnog mjehura bila je potpuna u svih bolesnika. U zaključku, 
rano transuretralno operacijsko zbrinjavanje opetovane BOO nakon transplantacije bubrega je siguran postupak koji daje 
izvrsne rezultate. 
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